GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans.
James M LutherJustina RayDawei WeiJohn R KoetheLaToya HannahAnthony DeMatteoRobert ManningAndrew S TerkerDungeng PengHui NianChang YuMona MashayekhiJorge GamboaNancy J BrownPublished in: Hypertension (Dallas, Tex. : 1979) (2021)
[Figure: see text].